1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position

   
   

The present invention are substituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (X) and unsubstituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (XI) such as the compound of EXAMPLE 13 ##STR1## which are useful in treating depression, obesity and other CNS disorders.

La actual invención es 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles substituido (x) y 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles sin sustituir (XI) por ejemplo el compuesto del ## del ## STR1 del EJEMPLO 13 que sean útiles en la depresión que trata, la obesidad y otros desórdenes del CNS.

 
Web www.patentalert.com

< NK1 antagonists

< Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes

> Conformational and topological protein regulation

> Glucagon antagonists/inverse agonists

~ 00173